In this work, we combine gene expression data from the Allen Atlas with brain maps of grey matter atrophy in symptomatic C9orf72, GRN and MAPT mutation carriers from the genetic FTD initiative (GENFI) study compared with non-carriers (Cash et al., 2018). This evidence concerns the gene GRN and frontotemporal dementia.